I’m surprised there is not more chatter about this PR. With Brazil on board, we should have no problem filling our new critical trials with any group of patients we may need. Also if it’s as dire as news reports are making it out to be, they need our help and will begin begging for it, once we start taking patients off ECMO. Management is working hard behind the scenes to push our molecule to any and all countries. The Brazil distributor sounds legitimate, being on the stock exchange. Keep the good news coming. We still need to hear one word for this thing to hit all time highs- REVENUE!!!! Probably not today, but very soon, is my opinion. Go CYDY!!!!